Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Agios Pharmaceuticals
AGIO
$2B
| $4.96M | ﹤0.01% |
175,191
-107,963
| -38% | -$2.69M |
|
3602
Syndax Pharmaceuticals
SNDX
$1.77B
| $4.96M | ﹤0.01% |
236,950
-1,342,719
| -85% | -$28M |
|
|
CTLT
3603
CALL
DELISTED
CATALENT, INC.
CTLT
| $4.95M | ﹤0.01% |
114,200
-58,100
| -34% | -$2.55M |
|
3604
PUT
Autoliv
ALV
$8.94B
| $4.95M | ﹤0.01% |
58,200
+48,200
| +482% | +$4.18M |
|
3605
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
| $4.95M | ﹤0.01% |
49,611
+37,574
| +312% | +$3.73M |
|
3606
PUT
Xerox
XRX
$407M
| $4.94M | ﹤0.01% |
332,000
-116,600
| -26% | -$1.71M |
|
3607
PUT
Frontier Group Holdings
ULCC
$1.54B
| $4.94M | ﹤0.01% |
511,000
-35,300
| -6% | -$317K |
|
3608
CALL
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $4.94M | ﹤0.01% |
104,800
+80,400
| +330% | +$3.68M |
|
3609
CRISPR Therapeutics
CRSP
$5.18B
| $4.94M | ﹤0.01% |
87,965
-86,374
| -50% | -$4.9M |
|
|
JBTM
3610
JBT Marel
JBTM
$6.23B
| $4.94M | ﹤0.01% |
40,690
-9,155
| -18% | -$1M |
|
3611
PUT
MP Materials
MP
$10.5B
| $4.94M | ﹤0.01% |
215,700
-481,400
| -69% | -$11M |
|
|
QVCGA
3612
DELISTED
QVC Group Inc Series A
QVCGA
| $4.93M | ﹤0.01% |
99,710
+86,131
| +634% | +$3.88M |
|
3613
PUT
Camping World
CWH
$662M
| $4.92M | ﹤0.01% |
163,600
+43,500
| +36% | +$1.1M |
|
|
CBAY
3614
DELISTED
Cymabay Therapeutics
CBAY
| $4.92M | ﹤0.01% |
449,462
+123,576
| +38% | +$1.15M |
|
3615
Nutrien
NTR
$32.6B
| $4.92M | ﹤0.01% |
83,345
+59,367
| +248% | +$3.78M |
|
3616
PUT
Lattice Semiconductor
LSCC
$18.5B
| $4.92M | ﹤0.01% |
51,200
-15,900
| -24% | -$1.37M |
|
3617
CALL
iShares MSCI Turkey ETF
TUR
$222M
| $4.91M | ﹤0.01% |
173,700
+132,600
| +323% | +$4.1M |
|
3618
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.91B
| $4.9M | ﹤0.01% |
49,292
+20,868
| +73% | +$2.07M |
|
3619
PUT
iShares US Transportation ETF
IYT
$2.28B
| $4.9M | ﹤0.01% |
78,400
-86,800
| -53% | -$4.98M |
|
|
HUT
3620
CALL
Hut 8
HUT
$10.5B
| $4.89M | ﹤0.01% |
296,080
+4,880
| +2% | +$50K |
|
3621
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $4.89M | ﹤0.01% |
97,370
+34,319
| +54% | +$1.73M |
|
3622
PUT
Algonquin Power & Utilities
AQN
$4.53B
| $4.88M | ﹤0.01% |
591,000
+358,700
| +154% | +$3.05M |
|
3623
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$329M
| $4.88M | ﹤0.01% |
34,900
+27,190
| +353% | +$4.53M |
|
3624
PUT
Gen Digital
GEN
$17B
| $4.88M | ﹤0.01% |
263,000
+38,300
| +17% | +$670K |
|
3625
CALL
Calumet Specialty Products
CLMT
$4.19B
| $4.88M | ﹤0.01% |
307,500
-122,300
| -28% | -$2.01M |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.